Jeff Hopkins Appointed CEO of FlowPhysix, Announces FLOWRUNNER™ Aspiration System Launch

Expanse Medical is pleased to announce the appointment of Jeff Hopkins as the new Chief Executive Officer and member of the Board of Directors at FlowPhysix, previously known as Expanse ICE. Mr. Hopkins, a seasoned leader with over 30 years of experience in the medical device industry, is set to guide FlowPhysix through a pivotal phase as the company transitions into its commercial stage.

With FDA clearance and demonstrated clinical success, FlowPhysix is preparing to launch its ICE Aspiration System under the new name FLOWRUNNER™ Aspiration System. Mr. Hopkins' extensive background includes leadership roles at Horizon Medical Products, Ethicon Endo-Surgery, Biosense Webster, and Acclarent, where he was instrumental in driving innovation and rapid growth. Notably, as Worldwide President of Acclarent, a Johnson & Johnson company, he successfully led a turnaround that culminated in the acquisition by Integra Life Sciences.

"We are thrilled to have Jeff join our team," said Eitan Konstantino, founder of Expanse Medical. "His visionary leadership and deep commercialization expertise make him the perfect leader to guide FlowPhysix through this exciting growth phase. We are confident that under his guidance, FlowPhysix will set new standards in thrombectomy and significantly improve patient outcomes worldwide."

In his new role, Mr. Hopkins will focus on building a world-class commercial organization and positioning FlowPhysix's strong pipeline to disrupt the vascular market. His appointment underscores the company's commitment to scaling operations to meet the increasing demand for effective endovascular thrombectomy solutions.

"I am excited to join FlowPhysix during this transformative period," Mr. Hopkins commented. "The FLOWRUNNER™ technology has the potential to revolutionize the treatment of vascular diseases, and I am eager to make these advancements accessible to as many patients as possible. I believe the FLOWRUNNER™ will establish a new standard of care for clot removal, creating a unique category of aspiration that aligns with natural physics. Early cases suggest that surgeons will have the ability to remove a wide range and volume of clots, effectively restoring blood flow."

FlowPhysix is poised to make significant strides in the medical device industry under Mr. Hopkins' leadership, with the FLOWRUNNER™ Aspiration System at the forefront of this exciting journey.